Tobacco and Public Health - TCSC Indonesia

ILSE HOFFMANN AND DIETRICH HOFFMANN 87
Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K-I., Makamura, S., et al. (1998). Increased
expression of cyclooxygenase-2 occurs frequently in human lung cancers, especially in
adenocarcinoma. Cancer Research, 58 (17), 3761–4.
Hoffmann, D. and Hecht, S. S. (1989). Advances in tobacco carcinogenesis. In: Handbook of
experimental pharmacology (ed. C. S. Cooper and P. L. Grover). Springer Publications, New York.
Hoffmann, D. and Hoffmann, I. (1997). The changing cigarette, 1950–1995. Journal of Toxicology and
Environmental Health, 50 (4), 307–64.
Hoffmann, D. and Wynder, E. L. (1963). Filtration of phenols from cigarette smoke. Journal of the
National Cancer Institute, 30, 67–84.
Hoffmann, D. and Wynder, E. L. (1967). The reduction in the tumorigenicity of cigarette smoke
condensate by addition of sodium nitrate to tobacco. Cancer Research, 27 (1), 172–4.
Hoffmann, D. and Wynder, E. L. (1971). A study of tobacco carcinogenesis. XI. Tumor initiation,
tumor acceleration, and tumor promoting activity of condensate fraction. Cancer, 27 (4), 848–64.
Hoffmann, D. and Wynder, E. L. (1977). Chemical analysis and carcinogenic bioassays of organic
particulate pollutants. In: Air pollution (ed. A. L. Stern), pp. 361–455. Academic Press, New York.
Hoffmann, D., Sanghvi, L. D., and Wynder, E. L. (1974). Comparative chemical analysis of India bidi
and American cigarette smoke. International Journal of Cancer, 14 (1), 49–53.
Hoffmann, D., Brunnemann, K. D., Prokopczyk, B., and Djordjevic, M. V. (1994). Tobacco-specific
N-nitrosamines and Areca-derived N-nitrosamines. Chemistry, biochemistry, carcinogenicity, and
relevance to humans. Journal of Toxicology and Environmental Health, 41 (1), 1–52.
Hoffmann, D., Hoffmann, I., and Wynder, E. L. (1998). The changing cigarette: 1950–1997: facts
and expectations. In Report of Canada’s Expert Committee on Cigarette Toxicity Reduction,
(ed. W. S. Rickert). Health Canada, Toronto, Ontario, Canada.
International Agency for Research on Cancer (1982). Di(2-ethylhexyl)phthalate. Some industrial
chemicals and dyestuffs. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals
to Humans 29, pp. 257–80. IARC, Lyon, France.
International Agency for Research on Cancer (1983). Polynuclear aromatic compounds. Part 1.
Chemical, environmental and experimental data. IARC Monographs on the Evaluation of the
Carcinogenic Risk of Chemicals to Humans 33. IARC, Lyon, France.
International Agency for Research on Cancer (1984). Coke production. Polynuclear aromatic compounds,
Part 3: Industrial exposure in aluminum production, coal gasification, coke production, and iron and
steel founding. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to
Humans 34, pp. 101–31. IARC, Lyon, France.
International Agency for Research on Cancer (1986a). Tobacco smoking. IARC Monographs on the
Evaluation of Carcinogenic Risks to Humans 38. IARC, Lyon, France.
International Agency for Research on Cancer (1986b). Amino acid pyrolysis products in food. Some
naturally occurring and synthetic food components, furocoumarins, and ultraviolet radiation. IARC
Monographs on the Evaluation of Carcinogenic Risks to Humans 40, pp. 233–80. IARC, Lyon, France.
International Agency for Research on Cancer (1987). Overall evaluation of carcinogenicity: An updating
of IARC monographs 1 to 42. IARC Monographs on the Evaluation of Carcinogenic Risks to
Humans Suppl. 7. IARC, Lyon, France.
International Agency for Research on Cancer (1988). Radon. Man-made mineral fibres and radon.
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 43, pp. 173–254. IARC,
Lyon, France.
International Agency for Research on Cancer (1991). DDT and associated compounds. Occupational
exposures in insecticide application, and some pesticides. IARC Monographs on the Evaluation of
Carcinogenic Risks to Humans 53, pp. 179–249. IARC, Lyon, France.